Mitochondrial Permeability Transition Dynamics: An Indicator of Mitochondrial Potassium Channel Opener


     Related Videos

     Related Hubpages

    •  Doc. Url:    Embed Code: 

    • IEEE  status
      (0) (0 Votes)
      Views: (2014)   Date: (Publication Date: 17-18 Jan. 2...)   Pages: ()
    • Author:  Fang Shen Li-ping Wu Yuan Lu Hua-wei Liang Bruce  I.C. Qiang Xia Dept. of Physiol.  Zhejiang Univ. Sch. of Med.  Hangzhou;  

    • Abstract:  Abstract Mitochondr ial permeability transition (MPT) is an intracellular event that is closely related to apoptosis and necrosis. However, whether this process underlies the recently reported neuroprotective potency of mitochondrial potassium channel openers applied in vivo remains uncertain. This study aims to clarify this issue by determining the effects of potassium channel openers on MPT dynamics in vitro along with their in vivo effects. Male Sprague-Dawley rats were subjected to middle cerebral artery occlusion (MCAO) for 90 min, followed by reperfusion. 30mul of diazoxide, an opener of the mitochondrial adenosine triphosphate-sensiti ve K+ channel (mitoKATP ), or NS1619, an opener of the mitochondrial Ca2+-activated potassium channel (mitoKCa) (2 mM and 0.1 mM respectively), was infused into the right lateral cerebral ventricle 15 min before the induction of ischemia. Neurological scores were assessed 24 h after MCAO and then infarct area was determined by standard 2,3,5-triphenyltetra zolium chloride staining techniques. To further clarify the capacity of diazoxide and NS1619 to protect mitochondria from Ca2+-induced MPT, we isolated brain-derived non-synaptosomal mitochondria and evaluated the effects of diazoxide and NS1619 on Ca2+-induced MPT dynamics through measurement of spectrophotometric alterations in light scattering at 520 nm. Neurological scores and infarct size were improved in animals pretreated with diazoxide and NS1619. In isolated mitochondria, MPT was readily induced by 200 muM Ca2+ and was effectively inhibited by diazoxide and NS1619. The specific MPT pore opener atractyloside abolished the inhibitory effects. According to time-constant analysis, MPT dynamics was in accordance with the neuroprotective effects of channel openers in vivo. Therefore, measuring MPT dynamics provides a new means of predicting the neuroprotective effects of mitochondrial potassium channel openers

         Related Documents

           Related Groups

             Related Science News

               More on Sciencestage

                 Answers

                 News
            • Foundation for Mitochondrial Medicine Awards Grant to Netherlands Research
              ATLANTA -- The Foundation for Mitochondrial Research, a US-based non-profit dedicated to funding research for the treatment of mitochondrial disease, has awarded a $50,000 grant to Professor Jan Smeitink ...
            • Mitochondrial Disease Study Suggests Targeted NGS is Helpful, But Many Patients Remain Undiagnosed
              Next-generation sequencing has been hailed as a tool that will end the "diagnostic odyssey" of patients with rare inherited disorders, but it has been unclear how often the technology is actually successful in pinpointing causative mutations and yielding a molecular diagnosis.
            • Researchers study mitochondrial function, potential new therapeutic target for Alzheimer's disease
              ( Rush University Medical Center ) Researchers at Rush University Medical Center are conducting an early phase clinical trial of a novel drug therapy for patients with dementia due to Alzheimer's disease.
            • Mitomics Announces U.S. Sales and Marketing Agreement with LabMD
              Mitomics, a world leader in the research and development of mitochondrial genome-based products, today announced a non-exclusive agreement with LabMD, Inc., an Atlanta-based clinic
            • Press Release
              Mitomics , a world leader in the research and development of mitochondrial genome-based products, today announced a non-exclusive agreement with LabMD, Inc., an Atlanta-based clinical pathology laboratory, to market Mitomics’ flagship product, the Prostate Core Mitomic Test™ (PCMT), in the United States.
            • RUMC conducts early phase trial of MSDC-0160 for dementia
              Researchers at Rush University Medical Center are conducting an early phase clinical trial of a novel drug therapy for patients with dementia due to Alzheimer's disease. The drug is a new compound called MSDC-0160, which is an insulin sensitizer that modulates mitochondrial metabolism.
            • Ian is flying high
              A DEBILITATING illness which has left a York man unable to walk and almost blind has not stopped him volunteering to jump from an aeroplane to raise money for research into the condition.
            • Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance
              Excessive levels of certain saturated fatty acids cause mitochondria to fragment, leading to insulin resistance in skeletal muscle, a precursor of type 2 diabetes, according to a paper in the January issue of the journal Molecular and Cellular Biology. This is the first time mitochondrial fragmentation has been implicated in insulin resistance, says corresponding author Yau-Sheng Tsai, of the ...
            • Scientists want kids with three parents
              SYDNEY scientists want to create designer babies with the DNA of three parents to prevent children inheriting life-threatening diseases.
            • DNA sequencing for difficult diagnoses of mitochondrial diseases may hit clinics soon
              Identifying complete DNA sequences could identify difficult-to-diagnose diseases in humans. This concept is being used for the first time in a clinic. MitoExome sequencing uses new technologies known as next-generation sequencing (NGS) to decode all of the genes associated with mitochondria. Mitochondria are a capsule shaped organelle present within the cell. It is the powerhouse of the cell and ...

                 Related on Wikipedia




























               

              Powered free by PHPmotion